000048614 000__ 02345cam\a22004575i\4500 000048614 001__ 48614 000048614 003__ SzGeWIPO 000048614 005__ 20240205101028.0 000048614 006__ m e d 000048614 008__ 231003s2023 sz ||||| |||||000|0 eng|d 000048614 0247_ $$2doi$$a10.34667/tind.48614 000048614 035__ $$aWIPO/PUB/RN2023-39/ExSum/EN 000048614 035__ $$a(OCoLC)1412052657 000048614 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL 000048614 041__ $$aeng 000048614 1001_ $$aAbbott, Frederick M.,$$eauthor. 000048614 24510 $$aIntellectual Property and Technology Transfer for COVID-19 Vaccines :$$bAssessment of the record - Executive Summary. 000048614 264_1 $$aGeneva, Switzerland :$$bWorld Intellectual Property Organization,$$c2023. 000048614 300__ $$a17 pages ;$$c[28] cm 000048614 336__ $$atext$$btxt$$2rdacontent 000048614 337__ $$aunmediated$$bn$$2rdamedia 000048614 338__ $$avolume$$bnc$$2rdacarrier 000048614 4901_ $$aWIPO Publication ;$$vNo. RN2023-39 000048614 520__ $$aThis Executive Summary concisely presents the results of an independent study commissioned by the World Intellectual Property Organization (WIPO)’s Global Challenges Division looking at the role played by intellectual property (IP) and technology transfer in the development, production and distribution of vaccines used to address the COVID-19 pandemic. The study uses a case-study approach to provide an in-depth analysis of some of the different approaches adopted by ten different global vaccine manufacturers, with respect to their funding, procurement, vaccine development and IP strategies (including licensing, technology transfer and access provisions). These experiences and lessons learnt provide practical insights to guide global policy-making on IP, health and access issues. 000048614 542__ $$fCC BY 4.0 000048614 650_4 $$aPatents$$zVaccines 000048614 650_4 $$aIntellectual property 000048614 650_4 $$aScience and technology 000048614 650_4 $$aTechnology transfer 000048614 650_0 $$aIntellectual property. 000048614 650_0 $$aPatents. 000048614 650_0 $$aTechnology transfer$$xLaw and legislation. 000048614 7101_ $$aWorld Intellectual Property Organization. 000048614 830_0 $$aWIPO Publication ;$$vNo. RN2023-39. 000048614 8564_ $$y10.34667/tind.48614$$9d1dbb7fc-6624-425e-8d48-63232810ba5a$$s1088966$$uhttps://tind.wipo.int/record/48614/files/wipo-pub-rn2023-39-exec-en-intellectual-property-and-technology-transfer-for-covid-19-vaccines-assessment-of-the-record.pdf 000048614 901__ $$aWIPO/PUB/RN2023-39/ExSum 000048614 902__ $$a48614_en 000048614 904__ $$aSummary 000048614 909__ $$ooai:tind.wipo.int: 48614$$pWIPOPUB 000048614 909__ $$ooai:tind.wipo.int:48614$$pWIPOPUB 000048614 909CO $$ooai:tind.wipo.int:48614$$pWIPOPUB 000048614 980__ $$aWIPOPUB